(Q34190743)

English

Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancer.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21652577%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancer (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21652577%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

decision making

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Jose A Garcia-Saenz

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21652577%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21652577%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21652577%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

author name string

J Albanell

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21652577%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

A González

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21652577%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

M Ruiz-Borrego

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21652577%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

E Alba

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21652577%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

J M Corominas

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21652577%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

O Burgues

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21652577%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

V Furio

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21652577%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

A Rojo

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21652577%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

J Palacios

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21652577%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

B Bermejo

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21652577%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

M Martínez-García

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21652577%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

M L Limon

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21652577%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

A S Muñoz

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21652577%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

M Martín

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21652577%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

I Tusquets

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21652577%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

F Rojo

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21652577%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

I Faull

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21652577%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

publication date

6 June 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21652577%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Annals of Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21652577%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21652577%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

625-631

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21652577%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21652577%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR278

21 January 2018

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR278

21 January 2018

Measurement of gene expression in archival paraffin-embedded tissues: development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR278

21 January 2018

Tumor gene expression and prognosis in breast cancer patients with 10 or more positive lymph nodes

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR278

21 January 2018

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR278

21 January 2018

Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR278

21 January 2018

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR278

21 January 2018

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR278

21 January 2018

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR278

21 January 2018

The influence of a gene expression profile on breast cancer decisions

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR278

21 January 2018

Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR278

21 January 2018

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR278

21 January 2018

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR278

21 January 2018

Breast cancer prognostic classification in the molecular era: the role of histological grade

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR278

21 January 2018

Proliferation marker Ki-67 in early breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR278

21 January 2018

Gene expression profiling predicts clinical outcome of breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR278

21 January 2018

Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR278

21 January 2018

Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR278

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34190743&oldid=1507808283"